university
A chat with Arizona’s dental school deans
Jack Dillenberg Dean, Arizona School of Dentistry, A.T.
Stem cell ruling stuns UB
A judge’s order ending federal funding for research using embryonic stem cells could have a $4 million negative impact on the University at Buffalo.
Healthcare facts n’ figures
An overwhelming majority of respondents(physicians, 91%) reported believing that physicians order more diagnostic tests and procedures than are needed in order to protect themselves from malpractice suits. Source : Physicians’ Views on Defensive Medicine A National Survey.
Apixaban, Xarelto deliver good results in studies
Pfizer and Bristol Myers Squibb’s blood thinner apixaban beat aspirin in a study that may open the door to a multi-billion dollar-a-year market to prevent clots. Meanwhile, rival drug
A Spoonful Of Sugar Won’t Help With Dosing
Would you be surprised to learn that many parents give their little ones an incorrect dose of liquid meds? A new study finds that using household spoons to measure needed dosages could result in an overdose and, not surprisingly, children under five are at the highest risk of such an accident, the BBC reports
Maxine Gowen – Top 10 Women in Biotech
Name: Maxine Gowen Current Company: Trevena Title: President & CEO Profile:
Financial pressures push UCH-Adventist Health merger
Declining financial performance may be driving University Community Health in Tampa to complete its proposed merger with Winter Park-based Adventist Health System.
Food Better Than Supplements for Cancer Prevention: Expert (HealthDay)
HealthDay – FRIDAY, Aug. 27 (HealthDay News) — Nutritional supplements are popular among Americans but people need to educate themselves and use caution when using these products to try to reduce their risk of cancer, says a University of Texas expert.
Should Pfizer Pay For Media To Learn About Cancer?
We spend a fair amount of time on this site tracking the controversy over continuing medical education and the extent to which industry may unduly influence the physician mindset.
The Ethics Of Overseas Pediatric Clinical Trials
A new study in Pediatrics finds more pediatric trials are going overseas – 65 percent conducted under the pediatric exclusivity provision, which offers drugmakers six months of patent extension for running safety and efficacy studies – used overseas sites. More than one-third, or 38 percent, enrolled patients in a developing country, including one-third of trials testing infectious disease, cardiovascular and allergy and immunology meds. And 11 per cent only used sites outside the US (here is the abstract )





